Orchestra BioMed Holdings, Inc.·4

Aug 25, 7:01 PM ET

Taylor Andrew Lawrence 4

4 · Orchestra BioMed Holdings, Inc. · Filed Aug 25, 2025

Insider Transaction Report

Form 4
Period: 2025-08-25
Taylor Andrew Lawrence
Chief Financial Officer
Transactions
  • Purchase

    Common Stock, par value $0.0001 per share

    2025-08-25$2.55/sh+2,000$5,100482,788 total

Documents

1 file
  • 4
    tm2524324-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT